Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Société Générale Director's Dealing 2021

Jan 28, 2021

1671_pos_2021-01-28_6d73b457-e829-4bc0-8ead-37c33c2d1760.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 1928N

Societe Generale SA

28 January 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1) Société Générale S.A.
Company dealt in Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.000304635 ordinary shares
Date of dealing 27/01/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long Short
Number (%) Number (%)
(1) Relevant securities 766,027 0.59 4,916 0.00
(2) Derivatives (other than options) 1,408 0.00 8,131 0.01
(3) Options and agreements to purchase/sell 0 0.00 0 0.00
Total *1,304,957 *1.01 13,047 0.01

* Include the holding of 537,522 shares on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale Number of relevant securities Price per unit USD (Note 5)
Purchase 18 205.95
Purchase 32 208.08
Purchase 18 206.02
Purchase 16 208.59
Purchase 29 207.81
Purchase 16 208.13
Purchase 100 205.99
Purchase 7 207.81
Purchase 14 207.89
Purchase 13 207.92
Purchase 37 205.97
Purchase 5 207.54
Purchase 100 205.61
Purchase 50 208.52
Sale 100 205.97
Sale 92 205.88
Sale 5 205.79
Sale 73 205.79
Sale 17 205.78
Sale 25 205.79
Sale 70 205.78
Sale 17 205.79
Sale 14 204.22
Sale 25 207.36
Sale 28 209.02
Sale 29 207.31
Sale 16 205.89
Sale 16 205.89
Sale 17 205.83
Sale 13 208.68
Sale 30 207.9
Sale 15 204.32
Sale 16 205.76
Sale 15 207.78
Sale 15 207
Sale 255 205.97
Sale 1 207.54
Sale 75 205.71
Sale 100 205.71
Sale 9 205.71
Sale 138 205.8
Sale 46 205.68
Sale 46 205.68
Sale 115 205.79
Sale 46 205.64
Sale 115 207.54
Sale 191 207.54
Sale 38 207.54
Sale 173 207.54
Sale 24 207.54
Sale 888 205.97
Sale 1,976 205.97
Purchase/sale Number of relevant securities Price per unit EUR (Note 5)
Sale 58 171
Total Purchases 455
Total Sales 4,942

(b)      Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit USD

(Note 5)

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any 

other person relating to the voting rights of any relevant securities under any optionreferred to on this 

form or relating to the voting rights or future acquisition or disposal of any relevant securities to which 

any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure 28/01/2021
Contact name Société Générale - Disclosure team
Telephone number +33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEVVLBLFFLXBBQ